Delivery Order SPE2DB22D1106-SPE2DB24FDYK5

Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,270.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564261561 ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The award has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor and there was no set-aside designation used for this award. This delivery order is part of a larger indefinite...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4564206271 ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $1,830.90 and a period of performance through April 9, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,483.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML medical products. The firm-fixed-price contract has a ceiling value of $7,076.79 and a performance period ending on May 14, 2024. Amerisourcebergen provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to various federal agencies, with a...
The Defense Logistics Agency Troop Support Medical has awarded a $18,813.39 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a $1,053.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This delivery order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML." The $1,467.42 contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,231.46 contract has a completion date of December 29, 2023 and was awarded on December 28, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and services to U.S. government agencies, primarily the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a potential value of $42,513.76. It is a firm fixed price delivery order contract with a completion date of February 2, 2024. Amerisourcebergen Drug Corp, as the prime...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order (SPE2DB22D1202|SPE2DB24FUWA7) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4564200773 ZEPBOUND 15 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,382.36 delivery order has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FDYK5
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a potential value of $1,191.75. The contract has a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is associated with a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.

Generated 5/2/24, 11:19 AM